[Immunologic tests: Anti-polymyositis-scleroderma (PM-Scl) antibody].
Takasaki
Yoshinari
Y
Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine.
D001323:Autoantibodies / Q000097:blood*; D001324:Autoantigens / Q000276:immunology*; D015415:Biomarkers / Q000097:blood; D003882:Dermatomyositis / Q000175:diagnosis* / Q000276:immunology; D005095:Exoribonucleases; D063326:Exosome Multienzyme Ribonuclease Complex; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D015151:Immunoblotting / Q000379:methods; D005779:Immunodiffusion / Q000379:methods; D047468:Immunoprecipitation / Q000379:methods; D017285:Polymyositis / Q000175:diagnosis* / Q000276:immunology; D012595:Scleroderma, Systemic / Q000175:diagnosis* / Q000276:immunology
D001323:Autoantibodies; D001324:Autoantigens; D015415:Biomarkers; D005095:Exoribonucleases; D063326:Exosome Multienzyme Ribonuclease Complex; C077044:EXOSC10 protein, human